Paper33848314
Physiological effects of intraperitoneal versus subcutaneous insulin infusion in patients with diabetes mellitus type 1: A systematic review and meta-analysis.
Dirnena-Fusini I and 4 others. PLoS One, 2021. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Physiological effects of intraperitoneal versus subcutaneous insulin infusion in patients with diabetes mellitus type 1: A systematic review and meta-analysis. Papers, record 33848314. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33848314
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 1 | Major topic |
| Hypoglycemic Agents | Major topic |
| Infusions, Parenteral | Major topic |
| Infusions, Subcutaneous | Major topic |
| Insulin | Major topic |
| Humans |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2227110 | Determination of portal insulin absorption from peritoneum via novel nonisotopic method. | Diabetes | 1990 | https://conductscience.org/library/papers/2227110 | PubMed |
| 2 | 510804 | The intravenous, intraperitoneal, and subcutaneous routes of insulin delivery in diabetic man. | Diabetes | 1979 | https://conductscience.org/library/papers/510804 | PubMed |
| 3 | 17141785 | No change in apolipoprotein AI metabolism when subcutaneous insulin infusion is replaced by intraperitoneal insulin infusion in type 1 diabetic patients. | Atherosclerosis | 2007 | https://conductscience.org/library/papers/17141785 | PubMed |
| 4 | 16091481 | Comparison of apolipoprotein B100 metabolism between continuous subcutaneous and intraperitoneal insulin therapy in type 1 diabetes. | J Clin Endocrinol Metab | 2005 | https://conductscience.org/library/papers/16091481 | PubMed |
| 5 | 3315766 | Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion. | Diabete Metab | 1987 | https://conductscience.org/library/papers/3315766 | PubMed |
| 6 | 9802775 | Autoimmunity and intraperitoneal insulin treatment by programmable pumps: lack of relationship. | Diabetes Care | 1998 | https://conductscience.org/library/papers/9802775 | PubMed |
| 7 | 1737538 | Normalization of composition of triglyceride-rich lipoprotein subfractions in diabetic subjects during insulin infusion with programmable implantable medication system. | Diabetes Care | 1992 | https://conductscience.org/library/papers/1737538 | PubMed |
| 8 | 20368215 | Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes? | Diab Vasc Dis Res | 2009 | https://conductscience.org/library/papers/20368215 | PubMed |
| 9 | 12774166 | Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. | Diabetologia | 2003 | https://conductscience.org/library/papers/12774166 | PubMed |
| 10 | 32166012 | Favourable serum calcification propensity with intraperitoneal as compared with subcutaneous insulin administration in type 1 diabetes. | Ther Adv Endocrinol Metab | 2020 | https://conductscience.org/library/papers/32166012 | PubMed |
| 11 | 2647606 | Effect of different insulin administration modalities on vitamin D metabolism of insulin-dependent diabetic patients. | Horm Metab Res | 1989 | https://conductscience.org/library/papers/2647606 | PubMed |
| 12 | 10954014 | Increased responses of glucagon and glucose production to hypoglycemia with intraperitoneal versus subcutaneous insulin treatment. | Metabolism | 2000 | https://conductscience.org/library/papers/10954014 | PubMed |
| 13 | 23865977 | Intraperitoneal insulin delivery to patients with type 1 diabetes results in higher serum IGF-I bioactivity than continuous subcutaneous insulin infusion. | Clin Endocrinol (Oxf) | 2014 | https://conductscience.org/library/papers/23865977 | PubMed |
| 14 | 2671601 | Comparison of intraperitoneal and subcutaneous insulin administration on lipids, apolipoproteins, fuel metabolites, and hormones in type I diabetes mellitus. | Metabolism | 1989 | https://conductscience.org/library/papers/2671601 | PubMed |
| 15 | 7007802 | The kinetics of peritoneal insulin absorption. | Metabolism | 1981 | https://conductscience.org/library/papers/7007802 | PubMed |
| 16 | 10633873 | Metabolic and hormonal responses to exercise in type 1 diabetic patients during continuous subcutaneous, as compared to continuous intraperitoneal, insulin infusion. | Diabetes Metab | 1999 | https://conductscience.org/library/papers/10633873 | PubMed |
| 17 | 10804326 | Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients. | Diabetes Metab | 2000 | https://conductscience.org/library/papers/10804326 | PubMed |
| 18 | 8960832 | Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM. | Diabetologia | 1996 | https://conductscience.org/library/papers/8960832 | PubMed |
| 19 | 8293863 | Experience with intraperitoneal insulin infusion from implantable programmable systems in type 1 (insulin-dependent) diabetes mellitus previously treated by external pumps. | Diabete Metab | 1993 | https://conductscience.org/library/papers/8293863 | PubMed |
| 20 | 1752346 | Variation of insulin absorption during subcutaneous and peritoneal infusion in insulin-dependent diabetic patients with unsatisfactory long-term glycaemic response to continuous subcutaneous insulin infusion. | Diabete Metab | 1991 | https://conductscience.org/library/papers/1752346 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42426563 | Continuous Intraperitoneal Insulin Infusion for People With Type 1 Diabetes: A Literature Review and International Position Statement. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/42426563 | PubMed |
| 40995084 | Continuous intraperitoneal insulin infusion as a valuable approach in patients with unstable type 1 diabetes: two case reports and a mini review of the literature. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40995084 | PubMed |
| 38509342 | Microfluidic-based systems for the management of diabetes. | Drug Deliv Transl Res | 2024 | https://conductscience.org/library/papers/38509342 | PubMed |
| 38437545 | Lipid nanoparticle structure and delivery route during pregnancy dictate mRNA potency, immunogenicity, and maternal and fetal outcomes. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38437545 | PubMed |
| 37715091 | The artificial pancreas: two alternative approaches to achieve a fully closed-loop system with optimal glucose control. | J Endocrinol Invest | 2024 | https://conductscience.org/library/papers/37715091 | PubMed |
| 37384782 | Accelerated absorption of regular insulin administered via a vascularizing permeable microchamber implanted subcutaneously in diabetic Rattus norvegicus. | PLoS One | 2023 | https://conductscience.org/library/papers/37384782 | PubMed |
| 35416407 | Pharmacokinetics of glucagon after intravenous, intraperitoneal and subcutaneous administration in a pig model. | Basic Clin Pharmacol Toxicol | 2022 | https://conductscience.org/library/papers/35416407 | PubMed |
| 34428558 | Structural principles of insulin formulation and analog design: A century of innovation. | Mol Metab | 2021 | https://conductscience.org/library/papers/34428558 | PubMed |
| 34100220 | Pharmacokinetics of Intraperitoneally Delivered Glucagon in Pigs: A Hypothesis of First Pass Metabolism. | Eur J Drug Metab Pharmacokinet | 2021 | https://conductscience.org/library/papers/34100220 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GCG | 2641 | PubTator's text mining | https://conductscience.org/library/genes/2641 | NCBI Gene |
| GH1 | 2688 | PubTator's text mining | https://conductscience.org/library/genes/2688 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| SERPINE1 | 5054 | PubTator's text mining | https://conductscience.org/library/genes/5054 | NCBI Gene |
| SHBG | 6462 | PubTator's text mining | https://conductscience.org/library/genes/6462 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33848314
GET https://conductscience.org/api/papers/v1/33848314/references?page=2